HFHaneen Husham Fadhil

Haneen Husham Fadhil

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haneen Husham Fadhil has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Serum leptin and glucagon-like peptide-1 levels in diabetic patients with end-stage renal disease on hemodialysis ‒ a cross-sectional study in Iraqi patients

    by Haneen Husham Fadhil, Rana Dawood Salman, Jubran Khaleel Hasan

    Introduction and aim. Diabetic kidney disease (DKD), a common complication of type 2 diabetes mellitus, is the leading cause of end-stage renal disease (ESRD). This study aimed to evaluate differences in serum leptin and glucagon-like peptide-1 (GLP-1) levels between diabetic ESRD patients undergoing hemodialysis and healthy controls. Material and methods. A cross-sectional observational study was conducted involving 65 participants: 31 type 2 diabetic patients with ESRD on hemodialysis and 34 healthy controls. Serum leptin and GLP-1 concentrations were measured using enzyme-linked immunosorbent assays. Results. Patients with ESRD exhibited significantly higher serum leptin levels (1.7±1.0 ng/mL) compared to controls (1.4±0.7 ng/mL; p=0.001), and significantly lower GLP-1 levels (19.6±11.2 pmol/L vs. 37.0±25.7 pmol/L; p=0.001). Conclusion. Elevated leptin levels and reduced GLP-1 concentrations in diabetic ESRD patients suggest a potential role of these biomarkers in renal injury and metabolic regulation. The findings highlight the therapeutic promise of GLP-1 receptor agonists in this population.

  • Open Access

    Synthesis, Characterization, and Anti-Breast Cancer Properties of Cu(II) Complexes with Schiff Base and Azo Dye Ligands

    by Haneen Fadhil Abbas, Faris Jassim Aldoghachi, Basil Abdulmahdi Salih, Yun Hin Taufiq-Yap

    This article focuses on the synthesis of three Schiff base ligands derived from 2-hydroxybenzaldehyde (B: BBr, BOCH3, BNO2) and three azo dye ligands derived from naphthol (A: ABr, AOCH3, ANO2), followed by the preparation of copper(II) complexes with these six ligands in a 1:2 (metal:ligand) ratio. The ligands and complexes were characterized by using 1H-NMR, 13C-NMR, FTIR, UV-vis, and ESI-MS. Thermogravimetric and differential thermal analyses of the copper complexes indicated the absence of water molecules in the crystalline coordination, demonstrating high thermal stability. The findings confirmed the formation of square-planar copper complexes. The biological activity of the complexes was evaluated on breast cancer and healthy cells using the MTT assay at different concentrations. The IC50 analysis showed that CuABr, CuBBr, and CuAOCH3 had a significantly more substantial cytotoxic effect on cancer cells than on healthy cells. CuBOCH3 and CuBNO2 also exhibited notable selectivity toward cancer cells, whereas CuANO2 was more toxic to normal cells. These findings highlight the potential of CuABr, CuBBr, and CuAOCH3 as promising candidates for further development in targeted breast cancer therapy.